Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of HIV Type 1
Status:
Completed
Trial end date:
2000-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study was to test the equivalence of a short zidovudine (ZDV) regimen as
compared to a longer, ACTG-076-like, ZDV regimen in reducing the risk of mother-to-child
transmission of HIV: and to assess and compare the safety and tolerance of the long and
shortened ZDV regimens.
Phase:
Phase 3
Details
Lead Sponsor:
Institut de Recherche pour le Developpement
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Harvard School of Public Health Harvard School of Public Health (HSPH)